Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Immune Therapeutics Inc (IMUND)

Immune Therapeutics Inc (IMUND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3
  • Shares Outstanding, K 0
  • Annual Sales, $ 0 K
  • Annual Income, $ 1,590 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.94
  • Price/Sales N/A
  • Price/Cash Flow 0.00
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1,760.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 07/05/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.5000 +110.00%
on 05/10/21
19.9500 -73.68%
on 05/11/21
-8.8500 (-62.77%)
since 05/03/21
3-Month
2.5000 +110.00%
on 05/10/21
26.0000 -79.81%
on 03/10/21
-13.7500 (-72.37%)
since 03/03/21
52-Week
2.5000 +110.00%
on 05/10/21
49.9000 -89.48%
on 07/08/20
-8.5500 (-61.96%)
since 06/03/20

Most Recent Stories

More News
Immune Therapeutics Announces Restructuring Plan

Orlando, Florida , June 04, 2021 (GLOBE NEWSWIRE) -- Immune Therapeutics Inc. (OTC-PINK: IMUN) (the "Company") announced today that the Company has received and signed a non-binding term sheet to enter...

IMUND : 5.2500 (-8.54%)
IMUN : 0.0930 (-7.00%)
Immune Therapeutics Announces Financing and Debt Restructuring Plan

Orlando, Florida, June 02, 2021 (GLOBE NEWSWIRE) -- Immune Therapeutics Inc. (OTC-PINK: IMUND) (the "Company") announced today that the Company has received and signed a non-binding term sheet to enter...

IMUN : 0.0930 (-7.00%)
IMUND : 5.2500 (-8.54%)

Business Summary

Forte Biotechnology Intl Corp is a biotechnology company. Its goal is to acquire late stage modulator drugs and immune modulator biopharmaceuticals for cancer, chronic inflammation, pain and neurodegenerative disease in companion pets. Forte Biotechnology Intl Corp, formerly known as Immune Therapeutics...

See More

Key Turning Points

3rd Resistance Point 6.0833
2nd Resistance Point 5.9167
1st Resistance Point 5.5833
Last Price 5.2500
1st Support Level 5.0833
2nd Support Level 4.9167
3rd Support Level 4.5833

See More

52-Week High 49.9000
Fibonacci 61.8% 31.7932
Fibonacci 50% 26.2000
Fibonacci 38.2% 20.6068
Last Price 5.2500
52-Week Low 2.5000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar